After just under three years as a stand-alone public company, Kenvue will be acquired by Kimberly-Clark Corporation, creating a $32 billion global health and wellness leader.WHO: Kenvue, the world's largest pure-play consumer health company by revenue, was spun out of Johnson & Johnson's consumer health segment and filed to be listed as an independent company under the ticker symbol KVUE in January 2023. Built on more than a century of heritage, their iconic brands, including Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena and Tylenol, are science-backed and recommended by healthcare professionals around the world.Kimberly-Clark and its trusted brands are in more than 175 countries and territories. Its portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva, and WypAll, hold no. 1 or no. 2 share positions in approximately 70 countries. The company's purpose is to deliver Better Care for a Better World.WHY: This transaction brings together two iconic American companies to create a combined portfolio of complementary products, including 10 billion-dollar brands, that touch nearly half the global population through every stage of life. The combined company, with teams around the globe, will harness a superior commercial engine—fueled by strategic customer partnerships, category-defining growth, industry-leading science and innovation, a differentiated digital model, best-in-class marketing, and a culture of operating excellence—to unlock the full potential of the combination and better meet the evolving needs of consumers.